SCHEMBL9565898

SCHEMBL9565898

c1ccc(NCn2ccnc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 7/20 0.55
CYP11B2 P19099 7/20 0.55
CYP19A1 P11511 3/20 0.55
QPCT Q16769 2/20 0.55
TBXAS1 P24557 2/20 0.55
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
POLB P06746 1/20 0.55
MAPT P10636 1/20 0.55
CYP4Z1 Q86W10 1/20 0.55
QPCTL Q9NXS2 1/20 0.55
CYP17A1 P05093 1/20 0.49
SOD1 P00441 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX15 P16050 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18457438 0.82 QPCT (0.56) CYP11B1CYP11B2CYP19A1QPCTTBXAS1
SCHEMBL10886757 0.80 MEN1 (0.56) CYP11B1CYP19A1QPCTTBXAS1MAPT
SCHEMBL11495035 0.80 SOD1 (0.67) CYP19A1QPCTSOD1
SCHEMBL7997986 0.76 CYP11B1 (0.55) CYP11B1CYP11B2CYP19A1QPCTTBXAS1
SCHEMBL10887453 0.76 ALDH1A1 (0.49) CYP11B1CYP11B2CYP19A1QPCTTBXAS1
SCHEMBL11420381 0.76 AGER (0.55) CYP19A1QPCTPOLB
SCHEMBL20659412 0.74 CYP11B1 (0.53) CYP11B1CYP11B2CYP19A1QPCTTBXAS1
SCHEMBL21076446 0.71 MGLL (0.62) CYP19A1QPCT
SCHEMBL22063900 0.71 CYP11B1 (1.00) CYP11B1CYP11B2CYP19A1QPCTTBXAS1
Benzylimidazole SCHEMBL414 0.71 CYP11B1 (1.00) CYP11B1CYP11B2CYP19A1QPCTTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0564356-A1 4-phenylaminomethylimidazole derivatives, process for their preparation, angiotensin II receptor antagonists and their application in therapy FOURNIER INDUSTRIE ET SANTE (FR) 1993-10-06 EP claimed
EP-0564356-A1 4-phenylaminomethylimidazole derivatives, process for their preparation, angiotensin II receptor antagonists and their application in therapy FOURNIER INDUSTRIE ET SANTE (FR) 1993-10-06 EP disclosed
EP-0564356-A1 4-phenylaminomethylimidazole derivatives, process for their preparation, angiotensin II receptor antagonists and their application in therapy FOURNIER INDUSTRIE ET SANTE (FR) 1993-10-06 EP disclosed
EP-0081324-B1 SUBSTITUTED PHARMACOLOGICALLY ACITVE IMIDAZOLE DERIVATIVES AND THEIR PREPARATION AND USE Farmos Group Ltd. (FI) 1986-08-06 EP disclosed